Chlormerodrin | hsa00220 | Arginine biosynthesis | 1.43E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | |
Chlormerodrin | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.51E-02 | 1 | P51649 | ALDH5A1 | More | |
Chlormerodrin | hsa00531 | Glycosaminoglycan degradation | 3.03E-02 | 1 | P15586 | GNS | More | |
Chlormerodrin | hsa01524 | Platinum drug resistance | 2.55E-02 | 2 | P04637, P48023 | TP53, FASLG | More | |
Chlormerodrin | hsa04068 | FoxO signaling pathway | 6.45E-03 | 2 | P48023, Q96BR1 | FASLG, SGK3 | More | |
Chlormerodrin | hsa04151 | PI3K-Akt signaling pathway | 4.21E-03 | 3 | P48023, P04637, Q96BR1 | FASLG, TP53, SGK3 | More | |
Chlormerodrin | hsa04612 | Antigen processing and presentation | 8.21E-03 | 5 | P26715, P26717, Q07444, Q13241, P01732 | KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | |
Chlormerodrin | hsa04650 | Natural killer cell mediated cytotoxicity | 1.37E-05 | 10 | P06239, P20963, P48023, Q13241, P26718, O14931, P26717, Q07444, Q14953, P26715 | LCK, CD247, FASLG, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KIR2DS5, KLRC1 | More | |
Chlormerodrin | hsa04658 | Th1 and Th2 cell differentiation | 7.09E-05 | 7 | Q04759, P20963, P09693, P06239, P23771, Q9UL17, Q13761 | PRKCQ, CD247, CD3G, LCK, GATA3, TBX21, RUNX3 | More | |
Chlormerodrin | hsa04659 | Th17 cell differentiation | 2.34E-03 | 6 | Q04759, P06239, Q9UL17, P23771, P09693, P20963 | PRKCQ, LCK, TBX21, GATA3, CD3G, CD247 | More | |
Chlormerodrin | hsa04660 | T cell receptor signaling pathway | 8.49E-04 | 7 | Q04759, O95267, Q08881, P20963, P09693, P01732, P06239 | PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, LCK | More | |
Chlormerodrin | hsa04722 | Neurotrophin signaling pathway | 2.27E-02 | 2 | P48023, P04637 | FASLG, TP53 | More | |
Chlormerodrin | hsa05146 | Amoebiasis | 2.73E-02 | 4 | P09341, P05089, P12814, P08311 | CXCL1, ARG1, ACTN1, CTSG | More | |
Chlormerodrin | hsa05160 | Hepatitis C | 3.81E-02 | 2 | P04637, P48023 | TP53, FASLG | More | |
Chlormerodrin | hsa05164 | Influenza A | 3.48E-02 | 2 | Q9GZY0, P48023 | NXF2; NXF2B, FASLG | More | |
Chlormerodrin | hsa05168 | Herpes simplex virus 1 infection | 4.54E-03 | 4 | P04637, Q9GZY0, P48023, P98182 | TP53, NXF2; NXF2B, FASLG, ZNF200 | More | |
Chlormerodrin | hsa05219 | Bladder cancer | 4.51E-02 | 1 | P04637 | TP53 | More | |
Chlormerodrin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.88E-03 | 5 | O95267, P20963, P09693, P06239, Q04759 | RASGRP1, CD247, CD3G, LCK, PRKCQ | More | |
Chlormerodrin | hsa05322 | Systemic lupus erythematosus | 1.57E-02 | 4 | P08311, P62807, Q16778, P12814 | CTSG, HIST1H2BC, HIST2H2BE, ACTN1 | More | |